Financial Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,968
Closed -$236K 64
2016
Q3
$236K Buy
3,968
+137
+4% +$8.01K 0.1% 53
2016
Q2
$211K Buy
+3,831
New +$204K 0.1% 55
2016
Q1
Sell
-4,097
Closed -$206K 62
2015
Q4
$206K Buy
+4,097
New +$207K 0.1% 53
2015
Q2
Sell
-6,984
Closed -$383K 51
2015
Q1
$383K Buy
6,984
+5
+0.1% +$283 0.19% 30
2014
Q4
$378K Buy
6,979
+5
+0.1% +$279 0.2% 31
2014
Q3
$394K Buy
6,974
+5
+0.1% +$281 0.22% 33
2014
Q2
$385K Buy
6,969
+1,257
+22% +$68.6K 0.22% 38
2014
Q1
$309K Sell
5,712
-870
-13% -$45K 0.17% 40
2013
Q4
$314K Buy
6,582
+631
+11% +$28.8K 0.18% 42
2013
Q3
$270K Hold
5,951
0.17% 38
2013
Q2
$264K Buy
+5,951
New +$266K 0.17% 38

Other funds holding MRK

Financial Advisory Group's MRK Position: Q4 2016 in Review

Financial Advisory Group sold out of Merck (MRK) in Q4 2016, closing a stake of 3,968 shares — an estimated $236K sold.

Financial Advisory Group first reported a position in MRK in Q2 2013 and held it in 11 quarters. The position peaked at $394K in Q3 2014. 1,912 funds tracked by Wall St. Rank hold MRK as of Q4 2016.

  • Financial Advisory Group reported no remaining Merck position as of Q4 2016 after selling out during the quarter.
  • Financial Advisory Group sold 3,968 Merck shares in Q4 2016, an estimated $236K.
  • Financial Advisory Group first reported a position in Merck in Q2 2013 and held it in 11 quarters.
  • Financial Advisory Group's Merck position peaked at $394K in Q3 2014.
  • 1,912 funds tracked by Wall St. Rank held Merck as of Q4 2016.

Based on Financial Advisory Group's 13F filing for Q4 2016, filed 5 Jan 2017.